SUM Earnings

SUM reported its FY2024Q3 earnings on 2024-10-30, showcasing a revenue of 1.11B against an estimate of 1.17B, resulting in a -4.64% surprise. The EPS was 0.75, surpassing the expected 0.7 by 7.14% . The stock experienced a 2.13% price change on the earnings day and a 9.87% change over the next five days, reflecting market reactions to the results.

Following SUM's FY2024Q3 earnings announcement on 2024-10-30, the stock price moved by 2.13% on the day of the release. Over the subsequent five days, it saw a 9.87% change. Historically, SUM's stock price tends to shift by an average of -2.35% in the 10 days leading up to earnings and +7.54% in the 10 days following, providing insight into potential market.

For 2024/Q4, analysts estimate SUM’s annual revenue to reach 1.01B, while the EPS is projected at 0.41. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by % and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.

The correlation between SUM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for were No Change by %, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SUM's stock price typically moves by -2.35% in the 10 days before its earnings and +7.54% in the 10 days after. For the upcoming 2024/Q4 earnings, analysts expect an EPS of 0.41 and revenue of 1.01B.

The earnings call presents mixed signals. Strong financial metrics, record high EBITDA margins, and positive shareholder return plans are offset by competitive pressures and weak guidance on volumes. The Q&A reveals cautious optimism with concerns on cost inflation and market conditions. The reaffirmed guidance and synergies are positives, but the lack of clarity in management's responses and potential risks from Argos USA integration temper expectations. Without market cap data, a neutral prediction (-2% to 2%) is prudent, balancing positives and uncertainties.